Rating Update: Stock Rating F-Lowest (1/11/24)-Repligen Corp (RGEN).
BUSINESS Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding […]